Zoetis

Research Report with COVID-19 Forecasts- Animal Health Diagnostics Market 2020-2024 | Rising Pet Adoption to Boost Growth | Technavio

Saturday, May 23, 2020 - 1:45am

Our animal health diagnostics market report covers the following areas:

Key Points: 
  • Our animal health diagnostics market report covers the following areas:
    This study identifies technological advances as one of the prime reasons driving the animal health diagnostics market growth during the next few years.
  • Animal health diagnostics market 2020-2024: Vendor Analysis
    We provide a detailed analysis of vendors operating in the animal health diagnostics market, including some of the vendors such as BioNote Inc., Heska Corp., IDEXX Laboratories Inc., IDvet, Randox Laboratories Ltd., SWISSAVANS AG, Teco Diagnostics, Thermo Fisher Scientific Inc., Virbac SA, and Zoetis Inc.
  • Backed with competitive intelligence and benchmarking, our research reports on the animal health diagnostics market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Animal health diagnostics market 2020-2024: Key Highlights

Zoetis to Participate in the Stifel 2020 Virtual Jaws & Paws Conference

Monday, May 18, 2020 - 1:30pm

Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2020 Virtual Jaws & Paws Conference on Wednesday, May 27, 2020.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2020 Virtual Jaws & Paws Conference on Wednesday, May 27, 2020.
  • Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations .
  • A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
  • Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses.

Outlook on the US Animal Vaccine Industry to 2025 - Analyst Insight & Current Market Trends - ResearchAndMarkets.com

Wednesday, April 29, 2020 - 1:56pm

US animal vaccine market is estimated to grow at a CAGR of around 6.6% during the forecast period.

Key Points: 
  • US animal vaccine market is estimated to grow at a CAGR of around 6.6% during the forecast period.
  • Significant awareness to maintain the health of pets and increasing animal healthcare expenditure is primarily contributing to the growth of the market.
  • This, in turn, is creating a exploring the possibilities growth of the US animal vaccine market.
  • Some crucial players in the US animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., Novartis International AG and United Vaccines, Inc.

Zoetis Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation

Friday, April 17, 2020 - 9:30pm

(NYSE: ZTS) has been notified of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) to purchase up to 1,000,000 shares of Zoetis common stock, representing approximately 0.21% of the outstanding shares of Zoetis common stock.

Key Points: 
  • (NYSE: ZTS) has been notified of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) to purchase up to 1,000,000 shares of Zoetis common stock, representing approximately 0.21% of the outstanding shares of Zoetis common stock.
  • Zoetis does not endorse TRCs unsolicited mini-tender offer and is not associated in any way with TRC, its mini-tender offer or its mini-tender offer documents.
  • TRCs offer price is below the current market value for shares of Zoetis common stock.
  • Zoetis therefore recommends that stockholders reject this unsolicited offer and not tender their shares in response to TRCs offer, or, if stockholders have already tendered shares, that they withdraw their shares by providing the written notice described in the TRC mini-tender offer documents prior to the expiration of the offer, currently scheduled for 12:01 a.m. (New York City time) on May 6, 2020.

Zoetis Named a Top Company for Executive Women by NAFE

Tuesday, March 3, 2020 - 3:55pm

(NYSE: ZTS) today announced that it has been named one of the 2020 Top 70 Companies for Executive Women by the National Association for Female Executives.

Key Points: 
  • (NYSE: ZTS) today announced that it has been named one of the 2020 Top 70 Companies for Executive Women by the National Association for Female Executives.
  • We are honored to once again be recognized by NAFE for our advancement and development programs for women, said Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Global Operations at Zoetis.
  • NAFE ranked Zoetis most highly for its workforce profile, including the number of women who hold leadership positions within the company, as well as its recruitment, retention and advancement programs for female employees.
  • Zoetis commitment to women starts with the companys diverse, twelve-member executive team, led by CEO Kristin Peck.

Zoetis Receives FDA Approval for Simparica Trio™, A New Combination Parasite Preventative for Dogs

Thursday, February 27, 2020 - 7:00pm

This combination product builds on the trusted legacy of Simparica (sarolaner) Chewables and exemplifies Zoetis dedication to innovation in parasiticides.

Key Points: 
  • This combination product builds on the trusted legacy of Simparica (sarolaner) Chewables and exemplifies Zoetis dedication to innovation in parasiticides.
  • Todays approval of Simparica Trio in the United States provides veterinarians with a new and effective combination parasiticide for dogs, said Catherine A. Knupp, DVM, MS, Executive Vice President and President, Research and Development at Zoetis.
  • Studies that support the approval of Simparica Trio showed:
    100% efficacy in preventing the development of heartworm disease.
  • In addition to receiving this approval, Zoetis has received approval for two parasiticide innovations in the U.S. in the past 18 months to help protect dogs and cats from harmful pests.

Zoetis to Participate in the Cowen and Company 40th Annual Health Care Conference

Friday, February 21, 2020 - 1:30pm

Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020, in Boston, Mass.

Key Points: 
  • Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020, in Boston, Mass.
  • Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts.
  • Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses.
  • Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.

Companion Animal Healthcare Market - Growth, Trends, and Forecast (2020 - 2025)

Thursday, February 20, 2020 - 4:10pm

Certain factors that are responsible for the growth of the companion animal healthcare market are increasing pet adoption across the globe, rising government initiatives for the sake of animal health, and growing technological advancements in the animal healthcare.

Key Points: 
  • Certain factors that are responsible for the growth of the companion animal healthcare market are increasing pet adoption across the globe, rising government initiatives for the sake of animal health, and growing technological advancements in the animal healthcare.
  • Further, the rising demand for pet healthcare insurance in the United States is expected to support this argument.
  • Thus, an increase in the number of diseases is expected to augment the growth of the vaccines market for companion animals.
  • The market for companion animal healthcare is majorly dominated by the few players such as Zoetis Inc., Bayer AG, Elanco, Virbac, etc.

$21Bn+ Veterinary Pharmaceuticals Market Analysis, 2015-2030 - Merck & Co, Zoetis, Eli Lilly & Company, Bayer, and Boehringer Ingelheim are Dominating

Monday, February 17, 2020 - 8:00pm

Major players in the market are Merck & Co, Zoetis, Eli Lilly and Company, Bayer, and Boehringer Ingelheim GmbH.

Key Points: 
  • Major players in the market are Merck & Co, Zoetis, Eli Lilly and Company, Bayer, and Boehringer Ingelheim GmbH.
  • North America was the largest region in the veterinary pharmaceuticals market in 2016, accounting for about 32% of the share in the market.
  • Increase in the prevalence rate of diseases among animals serves as one of the major drivers for the veterinary pharmaceuticals market.
  • Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

Zoetis Declares Second Quarter 2020 Dividend

Tuesday, February 11, 2020 - 9:36pm

(NYSE:ZTS) has declared a second quarter 2020 dividend payable to holders of the companys common stock of $0.20 per share.

Key Points: 
  • (NYSE:ZTS) has declared a second quarter 2020 dividend payable to holders of the companys common stock of $0.20 per share.
  • The dividend is to be paid on Monday, June 1, 2020, to holders of record on Friday, April 17, 2020.
  • Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses.
  • Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries.